Pertuzumab, sold under the brand name?Perjeta, is a?monoclonal antibody?used in combination with?trastuzumab?and?docetaxel?for the treatment of metastatic?HER2-positive?breast cancer; it also used in the same combination as a?neoadjuvant?in early HER2-positive breast cancer
Share ThisFacebookTwitterWhatsAppPinterestShare This
Reviews
There are no reviews yet.